Sensei PFO granted 80,000 stock options
Sensei Biotherapeutics’ principal financial and accounting officer, Josiah Craver, received a grant of stock options covering 80,000 shares of common stock on April 10, 2026.
Rhea-AI Filing Summary
Sensei Biotherapeutics’ principal financial and accounting officer, Josiah Craver, received a grant of stock options covering 80,000 shares of common stock on April 10, 2026. The options have an exercise price of $29.89 per share and expire on April 9, 2036.
According to the vesting terms, 25% of the shares subject to the option vest and become exercisable on April 10, 2027, with the remaining shares vesting in 36 equal monthly installments so that the award is fully vested by April 10, 2030, subject to his continuous service with the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 80,000 shares
Grant/Award
1 txn
Insider
Craver Josiah
Role
PFO & PAO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 80,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 80,000 contracts (Direct)
Footnotes (1)
- F1. 25% of the shares subject to the option vest and become exercisable on April 10, 2027, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter, such that the option is fully vested on the fourth anniversary of the date of grant, or April 10, 2030, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Key Figures
Option grant size: 80,000 options
Exercise price: $29.89 per share
Underlying shares: 80,000 shares
+4 more
7 metrics
Option grant size
80,000 options
Stock Option (right to buy) granted April 10, 2026
Exercise price
$29.89 per share
Conversion or exercise price of stock option
Underlying shares
80,000 shares
Underlying common stock for the option grant
Post-transaction derivative holdings
80,000 options
Total derivative securities following this transaction
Initial vesting date
April 10, 2027
25% of option shares vest and become exercisable
Full vesting date
April 10, 2030
Option fully vested on fourth anniversary of grant
Expiration date
April 9, 2036
Option expiration if not exercised
Key Terms
Stock Option (right to buy), exercise price, vest and become exercisable, equal monthly installments, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 29.8900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"25% of the shares subject to the option vest and become exercisable on April 10, 2027"
equal monthly installments financial
"remaining shares vest and become exercisable in 36 equal monthly installments thereafter"
continuous service financial
"subject to the Reporting Person's continuous service with the Issuer as of each such vesting date"
FAQ
What insider transaction did SNSE report for Josiah Craver on this Form 4?
Sensei Biotherapeutics reported that Josiah Craver received a grant of stock options for 80,000 shares of common stock. These options were awarded on April 10, 2026 and represent a compensation-related acquisition, not an open-market purchase or sale of existing shares.
What is the exercise price and size of Josiah Craver’s SNSE stock option grant?
The stock option grant to Josiah Craver covers 80,000 shares of Sensei Biotherapeutics common stock at an exercise price of $29.89 per share. This means he can later buy shares at $29.89, regardless of the market price, once the options have vested and are exercisable.
How do the SNSE stock options granted to Josiah Craver vest over time?
Twenty-five percent of the shares subject to the option vest and become exercisable on April 10, 2027. The remaining shares vest in 36 equal monthly installments after that date, so the entire 80,000-share option becomes fully vested by April 10, 2030, assuming continuous service.
When do Josiah Craver’s SNSE stock options expire if not exercised?
The stock options granted to Josiah Craver expire on April 9, 2036 if not exercised. After that expiration date, any unexercised portion of the 80,000-share option grant will no longer be exercisable, even if it had fully vested before expiration.
AI-generated analysis. How Rhea-AI works. Not financial advice.
